One of the links in the article is to Steve Kirsch's
http://www.skirsch.com/covid/Deaths.pdf.
"Anaphylaxis is a well known side effect and doctors are required to report it (see FDA Fact Sheet at the top of page 10) because it is considered a “severe adverse reaction.” It occurs right after the shot. You can’t miss it. It should always be reported. A study at Mass General Brigham (MGM) that assessed anaphylaxis in a clinical setting after the administration of COVID-19 vaccines published in JAMA on March 8, 2021, found “severe reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10,000 vaccinations.” This
rate is based on reactions occurring within 2 hours of vaccination, the mean time was 17 minutes after vaccination. This study used “active” surveillance and tried not to miss any cases."
251,000,000 people have received 1 or more doses of COVID vaccines (https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-... taking that 0.000247 rate at face value results in about 62,000 cases of anaphylaxis-related symptoms. VAERS reports 282, meaning 220x under-reporting, much worse than Kirsch's "As noted in the letter, this implies that VAERS is under-reporting anaphylaxis by 50X to 123X."
Unfortunately, anaphylaxis is not as bad as death and should be more common than death, right? But Kirsch also claims, right at the top of the paper, "The vaccines have killed over 150,000 Americans so far." So that's more than two times as many instances of a result that should be less common, by his own argument.
Somebody here isn't understanding statistics.
Oh, and about that 2.45/10,000 vaccinations? That paper is https://jamanetwork.com/journals/jama/fullarticle/2777417.
"In this prospective cohort of health care employees, 98% did not have any symptoms of an allergic reaction after receiving an mRNA COVID-19 vaccine. The remaining 2% reported some allergic symptoms; however, severe reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10 000 vaccinations. All individuals with anaphylaxis recovered without shock or endotracheal intubation. The incidence rate of confirmed anaphylaxis in this study is larger than that reported by the Centers for Disease Control and Prevention based on passive spontaneous reporting methods (0.025-0.11 per 10 000 vaccinations).1 However, the overall risk of anaphylaxis to an mRNA COVID-19 vaccine remains extremely low and largely comparable to other common health care exposures.4 Although cases were clinically compatible with anaphylaxis, the mechanism of these reactions is unknown."